Image – Interventional flashlight

DOI: 10.4244/EIJ-D-19-00138

Early experience with a purpose-designed temporary pacing guidewire for transcatheter valve implantation

Mark Hensey1, MB, BCh, BAO; David Daniels2, MD; David Wood1, MD; John G. Webb1, MD

Figure 1. The Wattson temporary pacing guidewire. A) SAPIEN 3 deployment in the aortic position with the Wattson wire. B) Tricuspid valve-in-valve with SAPIEN 3 with the Wattson wire. C) Pigtail with exposed electrodes (arrows). D) Pacing set-up with adaptor connected to external pacing device. E) Connection of adaptor. F) Adaptor release button (arrow).

Transcatheter heart valve implantation generally requires both a ventricular guidewire and a temporary transvenous pacemaker (TVP). TVP insertion is not without risks, namely vascular injury, cardiac perforation and tamponade1. The modification of a ventricular guidewire to deliver unipolar pacing for transcatheter aortic valve implantation (TAVI) has been validated2,3 and has also been described for tricuspid valve-in-valve (TViV) procedures4; however, this requires expertise, adds complexity and may result in high thresholds and unreliable pacing.

We describe the first-in-human experience with the purpose-designed Wattson™ temporary pacing guidewire (Teleflex, Maple Grove, MN, USA) for concomitant valve delivery and pacing. Three patients underwent TAVI and two underwent TViV with a balloon-expandable SAPIEN 3 (Edwards Lifesciences, Irvine, CA, USA) device (Figure 1A, Figure 1B). All valves were successfully implanted under rapid pacing using the Wattson wire. Mean pacing threshold was 2.2±0.45 mA, with sustained blood pressure drop and no loss of capture in any case. There was no pacing requirement post valve delivery and there were no complications.

Using a guidewire as a concomitant pacing wire reduces the risk of venous access-site complications, fluoroscopic time/dose and, notably, the risk of cardiac perforation. Pacing for TViV is particularly challenging as it may necessitate pacing wire placement in the left ventricle or coronary sinus, or guidewire modification.

The Wattson wire is 0.035” in diameter, 280 cm in length and offers similar stiffness to other commercially available moderate-support guidewires. It has a 3 cm diameter distal pigtail with multiple exposed electrodes providing predictable bipolar pacing (Figure 1C). The wire has an adaptor that connects the wire to a standard external pacemaker (Figure 1D-Figure 1F). If pacing is required post valve deployment, the wire length allows removal of the valve delivery system from the sheath while providing pacing and facilitating TVP insertion. In patients at high risk of needing longer-term pacing (e.g., pre-existing high degree atrioventricular block), an indwelling TVP might still be preferred.

In this small series, the Wattson wire offered reliable pacing and rail support for valve delivery in aortic and tricuspid positions. It could potentially make transcatheter valve implantation safer and more efficient but requires further clinical validation.

Conflict of interest statement

D. Daniels will receive royalties from the Wattson temporary pacing guidewire. D. Wood is a consultant to Edwards Lifesciences. J.G. Webb is a consultant to and has received research funding from Edwards Lifesciences, Abbott and Boston Scientific. The other author has no conflicts of interest to declare.

Volume 15 Number 6
Aug 9, 2019
Volume 15 Number 6
View full issue


Key metrics

Suggested by Cory

Research correspondence

10.4244/EIJ-D-23-00369 Nov 17, 2023
Direct wire pacing for transcatheter mitral valve replacement
Servoz C et al
free

Clinical research

10.4244/EIJ-D-18-01060 Nov 15, 2019
Pacemaker dependency after transcatheter aortic valve implantation: incidence, predictors and long-term outcomes
Costa G et al
free

EXPERT REVIEW

10.4244/EIJ-D-17_00487 Sep 24, 2017
Transcatheter tricuspid valve intervention: state of the art
Taramasso M and Maisano F
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
35.3

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.1

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.1

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved